Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.46 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1881512 | 1.00 | CYP2C19 (0.55) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2551111 | 1.00 | CYP2C19 (0.55) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| Methyl Alcohol SCHEMBL8740660 | 0.98 | CYP2C19 (0.54) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| Methyl Alcohol SCHEMBL8740648 | 0.98 | CYP2C19 (0.54) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| Alcohol SCHEMBL8740663 | 0.94 | CYP2C19 (0.50) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| Alcohol SCHEMBL8740664 | 0.94 | CYP2C19 (0.50) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL27822396 | 0.86 | CA1 (0.56) | CYP2C9CA1CA2NFKB1CA4 | |
| SCHEMBL11110869 | 0.85 | ALDH1A1 (0.46) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL11110867 | 0.85 | ALDH1A1 (0.46) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL27415289 | 0.85 | CYP2C19 (0.54) | CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113373466-B | Electrochemical synthesis method of beta-acetaminocarbonyl compound | 安徽科技学院 | 2023-07-21 | — | — | CN | disclosed |
| US-20230114794-A1 | METAL COMPLEX, INTERMEDIATE, AND PREPARATION METHOD AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2023-04-13 | — | — | US | disclosed |
| CN-111018918-B | Metal complex, intermediate, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2022-10-04 | — | — | CN | disclosed |
| CN-113373466-A | Electrochemical synthesis method of beta-acetaminocarbonyl compound | 安徽科技学院 | 2021-09-10 | — | — | CN | disclosed |
| EP-3865494-A1 | METAL COMPLEX, INTERMEDIATE, AND PREPARATION METHOD AND APPLICATION THEREOF | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2021-08-18 | — | — | EP | disclosed |
| EP-3271325-B1 | PROCESS OF PRODUCTION OF (S) -METOLACHLOR | ASCENZA AGRO S A (PT) | 2020-12-02 | — | — | EP | disclosed |
| US-6583305-B1 | Catalysts for enantioselective hydrogenation, hydroboration or 1,4 addition of olefins, ketones and imines | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2003-06-24 | — | — | US | disclosed |
| US-5990318-A | Soluble polyester-supported chiral phosphines | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 1999-11-23 | — | — | US | disclosed |
| US-5952527-A | A COMPLEX OF TRANSITIONAL METAL COMPOUND, CYCLOOCTADIENE OR CYCLOPENTADIENE AND 2,2-BIS/DIPHENYLPHOSPHINOAMINO/-5,5',6,6'7,7',8,8'-OCTAHYDRO-1 ,1'-BINAPHTHYL COMPOUND; USED AS HYDROGENATION CATALYST | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 1999-09-14 | — | — | US | disclosed |
| US-5919981-A | USING HYDROGENATION 1,1*-BINAPHTHYL-2,2*-DIAMINE AS CHEMICAL INTERMEDIATE | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 1999-07-06 | — | — | US | disclosed |
| EP-0564588-A1 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS. | ABBOTT LAB (US) | 1993-10-13 | — | — | EP | disclosed |
| US-5252751-A | Diphosphines containing silane groups, immobilised diphosphines and the use thereof as hydrogenation catalysts | CIBA-GEIGY CORPORATION (US) | 1993-10-12 | — | — | US | disclosed |
| US-5244857-A | DIPHOSPHINES CONTAINING SILANE GROUPS, IMMOBILISE DIPHOSPHINES AND THE USE THEREOF AS HYDROGENATION CATALYSTS | CIBA-GEIGY CORPORATION (US) | 1993-09-14 | — | — | US | disclosed |
| US-5223485-A | Oligopeptides as antiinflammatory agents | ABBOTT LABORATORIES (US) | 1993-06-29 | — | — | US | disclosed |
| WO-1992011858-A1 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1992-07-23 | — | — | WO | disclosed |
| EP-0456758-A1 | ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1991-11-21 | — | — | EP | disclosed |
| WO-1990009162-A2 | ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1990-08-23 | — | — | WO | disclosed |
| US-4438033-A | Steroidal chiral phosphines, methods for their preparation, catalytic systems containing them and catalytic processes in which they are used | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1984-03-20 | — | — | US | disclosed |
| US-4424312-A | COPOLYMERIZING N-ACRYLOYL-4-(DIPHENYLPHOSPHINO)-2--(DIPHENYLPHOSPHINOMETHYL)PYRROLIDINE, RHODIUM COMPLEX | POLYMER SCIENCES CORPORATION (US) | 1984-01-03 | — | — | US | disclosed |
| EP-0081149-A1 | New steroidal chiral phosphines, methods for their preparation, catalytic systems containing them and catalytic processes in which they are used | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1983-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230114794-A1 | METAL COMPLEX, INTERMEDIATE, AND PREPARATION METHOD AND APPLICATION THEREOF | AP2M1, AP3M1, AP1M1 | CYP2C19 238/4885CYP1A2 152/4885CYP3A4 498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.